Autoimmune Dementia Profile
Also known as: Autoimmune Dementia Panel, Paraneoplastic
Use
This test should be considered for the differential evaluation of patients who present with rapidly progressive dementia of undetermined etiology, especially with cognitive impairment and neuronal degeneration.
Special Instructions
Turnaround time is defined as the usual number of days from the date of pickup of a specimen for testing to when the result is released to the ordering provider. In some cases, additional time should be allowed for additional confirmatory or additional reflex tests. Testing schedules may vary.
Limitations
This test was developed and its performance characteristics determined by Labcorp in accordance with CLIA requirements. This test has not been cleared or approved by the Food and Drug Administration. A negative result does not exclude an autoimmune dementia. Additional factors such as clinical context and repeat testing may be necessary for a comprehensive diagnostic evaluation.
Methodology
Immunoassay (Immunofluorescence)
Biomarkers
LOINC Codes
- 56850-1
- 49738-8
- 43187-4
- 43102-3
- 84924-0
- 84925-7
- 84926-5
- 33422-7
- 43103-1
- 84927-3
- 82976-2
- 94347-2
- 96476-7
- 84929-9
- 84930-7
- 84931-5
- 84928-1
- 94345-6
- 82979-6
- 82978-8
Result Turnaround Time
5-7 days
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
2 mL
Minimum Volume
1 mL
Container
Gel barrier tube, serum transfer tube
Causes for Rejection
Gross hemolysis; grossly lipemic; gross icterus
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 14 days |
| Refrigerated | 14 days |
| Frozen | 14 days |